First National Bank Of Omaha Bio Techne Corp Transaction History

First National Bank Of Omaha

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $213,022 - $245,203	-467 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $184,621 - $223,635	-415 Reduced 47.05%	467 $226,000
Q1 2021 May 06, 2021	SELL	$314.62 - $411.0 $67,957 - $88,776	-216 Reduced 19.67%	882 $337,000
Q4 2020 Feb 18, 2021	BUY	$246.9 - $321.87 $33,084 - $43,130	134 Added 13.9%	1,098 $349,000
Q2 2020 Aug 05, 2020	SELL	$185.43 - $279.56 $35,973 - $54,234	-194 Reduced 16.75%	964 $255,000
Q1 2020 Apr 29, 2020	BUY	$161.17 - $221.51 $34,006 - $46,738	211 Added 22.28%	1,158 $220,000
Q4 2019 Jan 17, 2020	SELL	$189.68 - $222.09 $5.01 Million - $5.87 Million	-26,413 Reduced 96.54%	947 $208,000
Q2 2018 Jul 12, 2018	SELL	$144.9 - $165.58 $192,717 - $220,221	-1,330 Reduced 4.64%	27,360 $2.51 Million
Q1 2018 May 03, 2018	BUY	$131.46 - $151.04 $174,841 - $200,883	1,330 Added 4.86%	28,690 $2.71 Million
Q4 2017 Feb 05, 2018	BUY	$121.17 - $134.75 $3.32 Million - $3.69 Million	27,360	27,360 $2.51 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of Omaha with notifications on news.